Frances E Jensen MD FACP, FAAN, FANA
Epilepsy, Neurorehabilitation, Neurodegenerative
Chair, Department of Neurology, Perelman School of Medicine Professor of Neurology, University of Pennsylvania
Join to View Full Profile
3400 Civic Center Blvd# 2Philadelphia, PA 19104
Phone+1 215-662-3606
Fax+1 617-738-1542
Dr. Jensen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1984 - 1987- Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 1983 - 1984
Weill Cornell MedicineClass of 1983
Certifications & Licensure
PA State Medical License 2012 - 2026
MA State Medical License 1987 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Pilot Study of Bumetanide for Newborn Seizures Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- Hyperactive neuronal networks facilitate tau spread in an Alzheimer's disease mouse model.Aaron J Barbour, Keegan Hoag, Eli J Cornblath, Abigail Chavez, Alfredo Lucas
Biorxiv. 2024-12-03 - Basic Science and Pathogenesis.Aaron J Barbour, Abigail Chavez, Keegan Hoag, Xiaofan Li, Chloe Hassman
Alzheimer's & Dementia. 2024-12-01 - 6 citationsSeizures exacerbate excitatory: inhibitory imbalance in Alzheimer's disease and 5XFAD mice.Aaron J Barbour, Sarah Gourmaud, Eunjoo Lancaster, Xiaofan Li, David A Stewart
Brain. 2024-06-03
Press Mentions
Rapamycin: Potential to Slow Alzheimer's Disease in Seizure PatientsMay 8th, 2024- A Clearer Picture: State-of-the-Art Imaging Technology at the Pavilion Is Improving Diagnostics and Advancing Medical ResearchJanuary 13th, 2022
- Penn’s $1.6 Billion Pavilion Tower, Its Biggest yet, Opens with Massive Patient TransferOctober 30th, 2021
- Join now to see all
Grant Support
- Tracking the evolution of synaptic dysplasticity after early life seizuresUNIVERSITY OF PENNSYLVANIA2024–2027
- Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's DiseaseUNIVERSITY OF PENNSYLVANIA2022–2027
- Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's DiseaseUNIVERSITY OF PENNSYLVANIA2022–2027
- Remapping Clinical Neuroscience through Translation and Innovation Training (ReCoNnecT-IT)UNIVERSITY OF PENNSYLVANIA2015–2025
- Remapping Clinical Neuroscience through Translation and Innovation Training (ReCoNnecT-IT)UNIVERSITY OF PENNSYLVANIA2015–2025
- Remapping Clinical Neuroscience through Translation and Innovation Training (ReCoNnecT-IT)UNIVERSITY OF PENNSYLVANIA2015–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
